Collegium Pharmaceutical, Inc.

NasdaqGS:COLL 株式レポート

時価総額:US$967.5m

Collegium Pharmaceutical バランスシートの健全性

財務の健全性 基準チェック /26

Collegium Pharmaceuticalの総株主資本は$234.3M 、総負債は$867.2Mで、負債比率は370.2%となります。総資産と総負債はそれぞれ$1.6Bと$1.4Bです。 Collegium Pharmaceuticalの EBIT は$217.7Mで、利息カバレッジ比率4です。現金および短期投資は$145.0Mです。

主要情報

370.2%

負債資本比率

US$867.21m

負債

インタレスト・カバレッジ・レシオ4x
現金US$144.96m
エクイティUS$234.28m
負債合計US$1.40b
総資産US$1.64b

財務の健全性に関する最新情報

Recent updates

Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality

Nov 14
Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality

Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Oct 28
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Collegium Pharmaceutical: Diversifying And Growing

Aug 09

Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Right But Growth Is Lacking

Jul 24
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Right But Growth Is Lacking

Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly

Jun 05
Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly

Collegium Pharmaceutical: Some Positives From Its Quarterly 'Miss'

May 13

It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package

May 10
It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package

Collegium Pharmaceutical Q4: The Beat Goes On

Feb 26

These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well

Feb 24
These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well

There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues

Jan 05
There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues

Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly

Nov 12
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly

Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Aug 09
Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Mar 10
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?

Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Oct 18
Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?

Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet

Jun 24
Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet

Collegium Pharmaceutical: Oversold And Cheap

Jun 12

財務状況分析

短期負債: COLLの 短期資産 ( $443.8M ) は 短期負債 ( $459.4M ) をカバーしていません。

長期負債: COLLの短期資産 ( $443.8M ) は 長期負債 ( $941.4M ) をカバーしていません。


デット・ツー・エクイティの歴史と分析

負債レベル: COLLの 純負債対資本比率 ( 308.3% ) は 高い と見なされます。

負債の削減: COLLの負債対資本比率は、過去 5 年間で13.6%から370.2%に増加しました。

債務返済能力: COLLの負債は 営業キャッシュフロー によって 十分にカバー されています ( 22.3% )。

インタレストカバレッジ: COLLの負債に対する 利息支払いEBIT ( 4 x coverage) によって 十分にカバーされています


貸借対照表


健全な企業の発掘